Skip to main content
Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Open Chemistry Networks
      • Target 2035
      • CACHE
      • Women’s and Children’s Health Initiative
      • Conscience
      • READDI AViDD
      • Agora Open Science Trust
      • TREAT AD
      • EUbOPEN
      • YCharOS
      • Contribute your Proteins to Target 2035
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us
  • Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
        • EUbOPEN Chemogenomic Sets
        • KCGS
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Open Chemistry Networks
      • Target 2035
      • CACHE
      • Women’s and Children’s Health Initiative
      • Viral Medicines Initiative
      • READDI AViDD
      • Agora Open Science Trust
      • TREAT AD
      • EUbOPEN
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us

The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.

  • Read more about The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.

Structural characterization of a new N-substituted pantothenamide bound to pantothenate kinases from Klebsiella pneumonia and Staphylococcus aureus.

  • Read more about Structural characterization of a new N-substituted pantothenamide bound to pantothenate kinases from Klebsiella pneumonia and Staphylococcus aureus.

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.

  • Read more about EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.

  • Read more about Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.

Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.

  • Read more about Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.

The roles of Jumonji-type oxygenases in human disease.

  • Read more about The roles of Jumonji-type oxygenases in human disease.

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.

  • Read more about Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.

Structural genomics of human proteins.

  • Read more about Structural genomics of human proteins.

Salvage or recovery of failed targets by in situ proteolysis.

  • Read more about Salvage or recovery of failed targets by in situ proteolysis.

Case study--structural genomics and human protein kinases.

  • Read more about Case study--structural genomics and human protein kinases.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Current page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

A global public-private partnership that supports the discovery of new medicines through open-access research.

  • Careers
  • Contact Us

Structural Genomics Consortium. Registered charity 04714553 (England and Wales). Registered company limited by guarantee 1097737 (England and Wales). Except where otherwise noted, all content on this site is licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

Be the first to know with our SGC Bulletin!

Want to know what we are up to?
Leave your e-mail address below and you will receive a monthly source of SGC news from across our six research sites.

SIGN UP FOR OUR NEWSLETTER

Footer

  • Privacy Policy
  • Legal Information
  • Accessbility
  • Contact Us
  • Login

Toronto website development by Rebel Trail